National HealthCare (NHC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Jul, 2026Executive summary
Net operating revenues for 2025 increased 16.1% year-over-year to $1.52 billion, driven by an 8.4% rise in same-facility revenues and the full-year impact of the White Oak acquisition.
GAAP net income attributable to common stockholders was $120.0 million, up from $101.9 million in 2024; adjusted net income (non-GAAP) was $104.1 million, up from $76.9 million.
Skilled nursing facility occupancy improved to 89.7% in 2025 from 88.6% in 2024, with per diem rates rising across all payor types.
The White Oak acquisition added 15 skilled nursing, 2 assisted living, and 4 independent living facilities, contributing $227.5 million in net patient revenues.
Agency nurse staffing expenses decreased by 66.6% year-over-year, reflecting successful workforce management initiatives.
Financial highlights
Net patient revenues rose 17.4% to $1.47 billion; other revenues increased 4.3% to $48.2 million.
Total costs and expenses grew 14.1% to $1.39 billion, with salaries, wages, and benefits up 13.6% to $921.1 million.
Operating income increased to $128.4 million from $89.9 million in 2024.
Non-operating income was $18.1 million; unrealized gains on marketable equity securities were $22.3 million.
Diluted EPS was $7.67 (GAAP) and $6.65 (non-GAAP); dividends paid per share were $2.53.
Outlook and guidance
Management expects continued growth from the White Oak portfolio and ongoing improvements in skilled nursing census and per diem rates.
Short-term liquidity is supported by $92.8 million in cash and $163.0 million in unrestricted marketable equity securities.
Long-term liquidity is expected to be met through operating cash flows, real estate assets, and a $50 million credit line.
Latest events from National HealthCare
- Strong revenue and earnings growth, major acquisition, and new credit facility drive expansion.NHC
Q2 20243 Jul 2026 - Q3 2025 saw strong revenue growth and margin gains, but lease and investment risks remain.NHC
Q3 20253 Jul 2026 - 2024 net income surged 52.6% on 14.5% revenue growth, boosted by the White Oak acquisition.NHC
Q4 20243 Jul 2026 - Annual meeting to vote on director re-elections, say-on-pay, and review robust governance and ESG.NHC
Proxy filing3 Jul 2026 - Q3 2024 revenue and net income surged on rate hikes and the White Oak acquisition, with improved margins.NHC
Q3 20243 Jul 2026 - Revenue and earnings surged on acquisition and census gains, with strong liquidity and margin improvement.NHC
Q1 20253 Jul 2026 - Q2 2025 revenues surged 24.7% year-over-year, with adjusted net income up 64.7%.NHC
Q2 20253 Jul 2026 - Q1 2026 net income rose 11% to $35.9M; $560M facility acquisition announced for Q3 close.NHC
Q1 20263 Jul 2026 - 2026 proxy details director elections, say-on-pay, auditor change, and strong ESG focus.NHC
Proxy filing3 Jul 2026